Receptor Activator of Nuclear Factor κB Ligand (RANKL) Protein Expression by B Lymphocytes Contributes to Ovariectomy-induced Bone Loss

Similar Items

• RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice
  od: Fujiwara, Yuko, i dr.
  Izdano: (2016)
• The RANKL Distal Control Region Is Required for the Increase in RANKL Expression, But Not the Bone Loss, Associated with Hyperparathyroidism or Lactation in Adult Mice
  od: Onal, Melda, i dr.
  Izdano: (2012)
• Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency
  od: Xiong, Jinhu, i dr.
  Izdano: (2014)
• Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone
  od: Xiong, Jinhu, i dr.
  Izdano: (2015)
• Parathyroid Hormone Controls Receptor Activator of NF-κB Ligand Gene Expression via a Distant Transcriptional Enhancer
  od: Fu, Qiang, i dr.
  Izdano: (2006)